tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
INMB is currently covered by 2 analysts with an average price target of $18.32. This is a potential upside of $7.03 (62.27%) from yesterday's end of day stock price of $11.29.
INmune Bio's activity chart (see below) currently has 4 price targets and 4 ratings on display. The stock rating distribution of INMB is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 214.67 days.
Highest price target for INMB is $7, Lowest price target is $5, average price target is $18.32.
Most recent stock forecast was given by MAYANK MAMTANI from on 23-May-2022. First documented stock forecast 28-Jan-2021.
Currently out of the existing stock ratings of INMB, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
7
$-4.29 (-38.00%)
20
1 years 11 months 7 days ago
1/2 (50%)
$1.52 (27.74%)
13
Buy
14
$2.71 (24.00%)
31
1 years 11 months 7 days ago
1/2 (50%)
$8.52 (155.47%)
631
Buy
34
$23.48 (223.19%)
29
2 years 9 months 16 days ago
0/2 (0%)
$11.04 (48.08%)
What is INMB (INmune Bio) average time for price targets to be met?
Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?
Which analyst has the current lower performing score on INMB (INmune Bio) with a proven track record?
Which analyst has the most public recommendations on INMB (INmune Bio)?
Which analyst is the currently most bullish on INMB (INmune Bio)?
Which analyst is the currently most reserved on INMB (INmune Bio)?
